Screening Tools to Predict Treatment Outcome in Older Cancer Patients Who Are Undergoing Treatment

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

300 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

RATIONALE: Questionnaires that measure how well older patients think, learn, remember, and make judgments and carry out daily activities may improve the ability to plan treatment for patients with cancer.

PURPOSE: This clinical trial is studying testing for fitness to undergo chemotherapy to see how well it works in predicting treatment outcomes in older patients with cancer.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessment Tool for Older Patients With Cancer

NCT00477958

Cognitive/Functional Effects Psychosocial Effects of Cancer and Its Treatment Unspecified Adult Solid Tumor, Protocol Specific

ACTIVE_NOT_RECRUITING NA

Validation of a Screening Tool in Geriatric Oncology

NCT00963911

Breast Cancer Colorectal Cancer Head and Neck Cancer +3 more

COMPLETED NA

Assessing Older Patients With Cancer

NCT00416481

Unspecified Adult Solid Tumor, Protocol Specific

COMPLETED

Study of Physical and Mental Health of Older Patients With Newly Diagnosed Cancer

NCT00769951

Cognitive/Functional Effects Depression Hematopoietic/Lymphoid Cancer +5 more

COMPLETED

Geriatric Assessment in Predicting Chemotherapy Toxicity and Vulnerabilities in Older Patients With Cancer

NCT02517034

Solid Neoplasm

ACTIVE_NOT_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

OBJECTIVES:

* To assess the feasibility of applying screening tools (Groningen Frailty Indicator \[GFI\] and G8) and their relationship to treatment outcome in older patients with cancer undergoing standard treatment versus geriatric interventions.
* To compare the screening tools (GFI and G8) with a comprehensive geriatric assessment (CGA).
* To evaluate the predictive value of the screening tool to undergo standard anticancer treatment in terms of toxicity.
* To identify patients that can benefit from a geriatric intervention in order to be able to undergo standard anticancer treatment.

OUTLINE: This is a multicenter study.

All patients complete screening questionnaires (GFI, G8, and the standardized CGA which consists of the ADL (Katz index) and IADL; the Timed Up and Go; the Cancer and Leukemia Group B adaptation of Charlson Co-morbidity; the Mini Nutritional Assessment; the RAND Social Support Survey Instrument; the Folstein Mini Mental State Examination; and the Geriatric Depression Scale) before the start of anticancer treatment, prior to each course of treatment, and after 1 month of treatment. Patients also undergo physical and cognitive performance measures by a trained member of the research team. Patients are assigned to a group based on fitness for treatment. They may be reassigned after each round of assessments.

* Group 1 (fit to undergo standard treatment): Patients undergo standard treatment.
* Group 2 (vulnerable): Patients receive specialized care and individualized treatment.
* Group 3 (frail): Patients receive palliative care and no anticancer chemotherapy or targeted agents.

Patients' medical history, vital signs, performance status, physical examination, and body weight are obtained and recorded. In patients receiving anticancer treatment, all adverse events are graded according to the National Cancer Institute Common Toxicity Criteria (NCI-CTC) and recorded and serious adverse events will be reported according to European Rules.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Unspecified Adult Solid Tumor, Protocol Specific

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Primary Study Purpose

SUPPORTIVE_CARE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

questionnaire administration

Intervention Type OTHER

cognitive assessment

Intervention Type PROCEDURE

examination

Intervention Type PROCEDURE

management of therapy complications

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* No severe known dementia
* No pre-existing major neurological or psychiatric problems
* No refusal of the standard anticancer strategy as defined by the service instruction book

PRIOR CONCURRENT THERAPY:

* See Disease Characteristics

Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No